The Global Losartan Potassium market volume was roughly 24 thousand tonnes in 2023 and is anticipated to grow at a CAGR of 4.8% during the forecast period until 2034.
Losartan Potassium or Losartan is primarily used for the treatment of hypertension (high blood pressure) in adults and certain children. It is also utilized to improve kidney function in individuals with diabetes. Additionally, it is employed to mitigate the risk of stroke in individuals with high blood pressure and a heart condition known as left ventricular hypertrophy. This prescription drug is available in oral tablet form, marketed under the brand name Cozaar as well as in generic form, typically costing less than its branded counterpart. It may be prescribed as part of a combination therapy alongside other medications to effectively lower blood pressure. Losartan falls under the drug class called angiotensin receptor blockers (ARBs), which includes other medications like Olmesartan, valsartan, and telmisartan. These drugs function similarly and are commonly prescribed for the treatment of hypertension and various heart-related conditions.
The increasing prevalence of hypertension, driven by aging populations and unhealthy lifestyle choices, fuels the demand for antihypertensive medications like Losartan. Sedentary lifestyles and poor dietary habits contribute to elevated blood pressure levels, necessitating effective management with medications such as Losartan. Additionally, heightened awareness of the risks associated with untreated hypertension prompts individuals to seek medical intervention, further driving demand. Losartan's efficacy and tolerability, coupled with its availability in generic form, make it a preferred choice for both patients and healthcare providers, particularly in regions with limited healthcare resources. Moreover, the rising geriatric population, prone to hypertension, intensifies the need for effective treatments like Losartan to maintain optimal blood pressure levels and cardiovascular health. Its mechanism of action as an angiotensin II receptor blocker (ARB) makes it particularly suitable for elderly patients, with its safety profile and clinical efficacy driving its increased use in this demographic. The expiration of patents for brand-name Losartan medications has led to the introduction of generic versions, further expanding access to this essential medication and driving its demand among a broader population. The global Losartan Potassium market is likely to reach approximately 42 thousand tonnes in 2034.
Geographically, North America is the largest consumers of Losartan Potassium. The reasons include the region's large and aging population, coupled with a high prevalence of hypertension and related cardiovascular conditions, contributes to significant demand for antihypertensive medications like Losartan Potassium. Additionally, North America has a well-established healthcare infrastructure and advanced medical facilities, facilitating widespread access to prescription medications and increasing the likelihood of Losartan Potassium utilization among patients. Moreover, extensive healthcare coverage and insurance systems in countries like the United States further encourage the use of Losartan Potassium as a preferred treatment option for hypertension management. Furthermore, robust research and development activities in the pharmaceutical sector in North America contribute to the continuous innovation and availability of Losartan Potassium formulations, meeting the diverse needs of patients.
Based on end-use applications, the global Losartan Potassium market is divided into Hypertension, Heart Stroke, Kidney Disease, and Others. Losartan is often prescribed for the management of kidney disease in patients diagnosed with type 2 diabetes besides the treatment of Hypertension.
Major players in the Global Losartan Potassium market are Dr. Reddy's Laboratories, Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis International AG, Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., and Others.
Years considered for this report:
Historical Period: 2015- 2022
Base Year: 2023
Estimated Year: 2024
Forecast Period: 2025-2034
This report will be delivered on an online digital platform with one-year subscription and quarterly update.
Objective of the Study:
• To assess the demand-supply scenario of Losartan Potassium which covers production, demand and supply of Losartan Potassium market in the globe.
• To analyse and forecast the market size of Losartan Potassium
• To classify and forecast Global Losartan Potassium market based on end-use and regional distribution.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., of Losartan Potassium market in the globe.
To extract data for Global Losartan Potassium market, primary research surveys were conducted with Losartan Potassium manufacturers, suppliers, distributors, wholesalers and Traders. While interviewing, the respondents were also inquired about their competitors. Through this technique, ChemAnalyst was able to include manufacturers that could not be identified due to the limitations of secondary research. Moreover, ChemAnalyst analyzed various segments and projected a positive outlook for Global Losartan Potassium market over the coming years.
ChemAnalyst calculated Losartan Potassium demand across the globe by analyzing the volume of Losartan Potassium consumed by the End-Use Applications and the forecast is calculated based on the growth rate of end-use industries. ChemAnalyst sourced these values from industry experts and company representatives and externally validated them by analyzing the historical sales data of respective manufacturers to determine the overall market size. Various secondary sources such as company websites, association reports, annual reports, etc., were also studied by ChemAnalyst.
Key Target Audience:
• Losartan Potassium manufacturers and other stakeholders
• Organizations, forums and alliances related to Losartan Potassium distribution
• Government bodies such as regulating authorities and policy makers
• Market research organizations and consulting companies
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as Losartan Potassium manufacturers, customers and policy makers. The study would also help them to target the growing segments over the coming years (next two to five years), thereby aiding the stakeholders in taking investment decisions and facilitating their expansion.
Report Scope:
In this report, Global Losartan Potassium market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Attribute
Details
Market size Volume in 2023
24 thousand tonnes
Market size Volume in 2034
42 thousand tonnes
Growth Rate
CAGR of 4.8% from 2024 to 2034
Base year
2023
Estimated year
2024
Historical Data
2015 – 2022
Forecast period
2025 – 2034
Quantitative units
Demand in thousand tonnes and CAGR from 2024 to 2034
Report coverage
Industry Market Size, Capacity by Company, Capacity by Location, Operating Efficiency, Production by Company, Demand by End-Use Application, Demand by Region, Demand by Distribution Channel, Demand-Supply Gap, Company Share, Manufacturing Process.
Segments covered
By End-Use Application: (Hypertension, Heart Stroke, Kidney Disease, and Others)
By Sales Channel: (Direct Sale and Indirect Sale)
Regional scope
North America, Europe, Asia Pacific, Middle East and Africa, and South America.
With the given market data, ChemAnalyst offers customizations according to a company’s specific needs.
In case you do not find what, you are looking for, please get in touch with our custom research team at sales@chemanalyst.com
Market Data & Insights
Table of Content
1. Industry Market Size
It is an essential metric for market analysis, as it provides insights into the overall size and growth potential of Losartan Potassium market in terms of value and volume.
2. Capacity By Company
On our online platform, you can stay up to date with essential manufacturers and their current and future operation capacity on a practically real-time basis for Losartan Potassium.
3. Capacity By Location
To better understand the regional supply of Losartan Potassium by analyzing its manufacturers' location-based capacity.
4. Plant Operating Efficiency
To determine what percentage manufacturers are operating their plants or how much capacity is being currently used.
5. Production By Company [Quarterly Update]
Study the historical annual production of Losartan Potassium by the leading players and forecast how it will grow in the coming years.
6. Demand by End-Use Applications [Quarterly Update]
Discover which end-user application (Hypertension, Heart Stroke, Kidney Disease, and Others) are creating a market and the forecast for the growth of the Losartan Potassium market.
7. Demand by Region
Analyzing the change in demand of Losartan Potassium in different regions, i.e., North America, Europe, Asia Pacific, Middle East and Africa, and South America, that can direct you in mapping the regional demand.
8. Demand by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
Multiple channels are used to sell Losartan Potassium. Our Distribution Channel will help in analyzing whether Hospital Pharmacy, Retail Pharmacy, or Online Pharmacy make up most of the industry's sales.
9. Demand-Supply Gap
Determine the supply-demand gap to gain information about the trade surplus or deficiency of Losartan Potassium.
10. Company Share
Figure out what proportion of the market share of Losartan Potassium is currently held by leading players across the globe.
11. Manufacturing Process
Discover insights into the intricate manufacturing process of Losartan Potassium.
I am satisfied with overall performance of ChemAnalyst. Weekly updates before the final report were especially helpful and reassuring. Additional requests on the interim and/or final reports were handled in a swift and professional manner
Mr.Shin Dosho
Member - Board of Directors
Osaka Gas Co. Ltd
Disruption Tracker
Disruption Tracker reflect the major shutdown on monthly basis which will help you in
tracking the inventory management and smooth functioning of business. Unforeseen shutdowns and disruptions
resulting in a loss of production capacity to impact the bottom line. The capacity tracker provides industries
with a global view of production and consumption capacity loss that reflects the corresponding conversion factors.
It also highlights the immediate impact on supply due to planned and unplanned outages as well as upcoming start-up
of new capacities. Additionally, it emphasizes how each shutdown—whether due to a maintenance turnaround or a case
of force majeure, affects the plant's operating rate for the given duration. Disruption tracker gives a clear insight
into the worldwide outages affecting the commodity of interest. With every shutdown, it also reflects the impact on
supply of the product in the market at a Global level.
What was the net market size of Losartan Potassium in terms of volume in 2023?
Ans:
The global market size of Losartan Potassium has reached approximately 24 thousand tonnes in 2023.
Q2.
Which region is the largest consumer of Losartan Potassium?
Ans:
North America is the largest consumer of Losartan Potassium globally.
Q3.
Do you offer single or multiuser license?
Ans:
Online Access 12 Months – Single User License (Up to 3 users can access the database)
Online Access 12 Months – Enterprise License (Up to 10 Users can access the database)
Q4.
Will I get access to the analyst who authored this report?
Ans:
You will have 24/7 access to the analyst during the subscription period.
Our Solutions
Custom Research
We at ChemAnalyst provide tailor-made solutions to our clients based on their requirements which help them in building and expanding their business by developing customized strategy such as sales strategy, GTM Strategy, product portfolio and new product development. Our dedicated team helps clients in getting the best solution for their requirements. We at ChemAnalyst look forward to serving our clients for long term association.
Techno Economic Feasibility Report (TEFR)
ChemAnalyst provide TEFR reports which include market sizing, plant cost (ISBL and OSBL units), financial modelling, covering all the major financial calculations and ratios including production cost, IRR, major technology, licensing fee (if required), and others fixed and variable costs. TEFR reports will help the client to build greenfield project as well as brownfield expansion for a specific geography. Our Team of experts have delivered multiple TEFR reports which help clients in moving ahead of their business competition by grabbing the opportunity and expanding their business portfolio.
Price Benchmarking
Pricing benchmark report provides real-time data perpetuating current market scenarios, in a world that is changing at a rapid pace, having real-time prices is an imperative to make impactful insights and thereby informed decisions. The Price Benchmarking report provides pricing data for an individual market, or group of markets, which can be converted into localized insights and comparable listings. Benchmarking Reports help clients to make informed decisions by construing the data on several filters: region, country, category, grade and subsequently increasing their brand presence. Clients majorly require pricing benchmarks when they opt for a competitive pricing strategy.